Form 4: Rockwell Medical Director John G. Cooper Acquires Shares Through Restricted Stock Units

Director John G. Cooper acquired 36,111 shares of Rockwell Medical, Inc. common stock through restricted stock units, according to a recent SEC Form 4 filing.

Summary

• John G. Cooper, a director at Rockwell Medical, Inc., acquired 36,111 shares of common stock on May 21, 2024.
• The acquisition was through restricted stock units (RSUs) at a price of $0.
• These RSUs vest on May 21, 2025, contingent upon Cooper's continued service to the company.
• Following the transaction, Cooper directly owns 95,451 shares of Rockwell Medical, Inc.
• The filing also includes a Power of Attorney, effective February 1, 2024, authorizing Mark Strobeck, Megan Timmins, and Ryan Murr to file Section 16 forms on Cooper's behalf.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It reflects a routine transaction by a company director. The acquisition of shares could be seen as a positive sign, but it's not a major event.

Positives

• The acquisition of shares by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The vesting of the restricted stock units is contingent upon the reporting person's continued service to the issuer.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a director's acquisition of shares, which is a common occurrence.

Stakeholder Impact

• The acquisition of shares by a director could have a slightly positive impact on shareholder sentiment.

Key Dates